- -

Pitfalls to be considered on the metabolomics analysis of biological samples by HR-MAS

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Pitfalls to be considered on the metabolomics analysis of biological samples by HR-MAS

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Esteve Moya, Vicent es_ES
dc.contributor.author Martínez-Granados, Beatriz es_ES
dc.contributor.author Martínez-Bisbal, M.Carmen es_ES
dc.date.accessioned 2016-07-18T12:36:24Z
dc.date.available 2016-07-18T12:36:24Z
dc.date.issued 2014-05
dc.identifier.issn 2296-2646
dc.identifier.uri http://hdl.handle.net/10251/67744
dc.description This Document is Protected by copyright and was first published by Frontiers. All rights reserved. it is reproduced with permission es_ES
dc.language Inglés es_ES
dc.publisher Frontiers Media es_ES
dc.relation.ispartof Frontiers in Chemistry es_ES
dc.rights Reserva de todos los derechos es_ES
dc.subject HR-MAS NMR es_ES
dc.subject Metabolomics/metabolite profiling es_ES
dc.subject Biological samples es_ES
dc.subject NMR spectroscopy es_ES
dc.subject ERETIC es_ES
dc.title Pitfalls to be considered on the metabolomics analysis of biological samples by HR-MAS es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.3389/fchem.2014.00033
dc.rights.accessRights Abierto es_ES
dc.description.bibliographicCitation Esteve Moya, V.; Martínez-Granados, B.; Martínez-Bisbal, M. (2014). Pitfalls to be considered on the metabolomics analysis of biological samples by HR-MAS. Frontiers in Chemistry. 2:1-3. doi:10.3389/fchem.2014.00033 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion http://dx.doi.org/10.3389/fchem.2014.00033 es_ES
dc.description.upvformatpinicio 1 es_ES
dc.description.upvformatpfin 3 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 2 es_ES
dc.relation.senia 275165 es_ES
dc.identifier.pmcid PMC4038765 en_EN
dc.description.references Akoka, S., Barantin, L., & Trierweiler, M. (1999). Concentration Measurement by Proton NMR Using the ERETIC Method. Analytical Chemistry, 71(13), 2554-2557. doi:10.1021/ac981422i es_ES
dc.description.references Albers, M. J., Butler, T. N., Rahwa, I., Bao, N., Keshari, K. R., Swanson, M. G., & Kurhanewicz, J. (2009). Evaluation of the ERETIC method as an improved quantitative reference for1H HR-MAS spectroscopy of prostate tissue. Magnetic Resonance in Medicine, 61(3), 525-532. doi:10.1002/mrm.21808 es_ES
dc.description.references Bathen, T. F., Sitter, B., Sjobakk, T. E., Tessem, M.-B., & Gribbestad, I. S. (2010). Magnetic Resonance Metabolomics of Intact Tissue: A Biotechnological Tool in Cancer Diagnostics and Treatment Evaluation. Cancer Research, 70(17), 6692-6696. doi:10.1158/0008-5472.can-10-0437 es_ES
dc.description.references Ben Sellem, D., Elbayed, K., Neuville, A., Moussallieh, F.-M., Lang-Averous, G., Piotto, M., … Namer, I. J. (2011). Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy. Journal of Oncology, 2011, 1-9. doi:10.1155/2011/174019 es_ES
dc.description.references Bourne, R., Dzendrowskyj, T., & Mountford, C. (2003). Leakage of metabolites from tissue biopsies can result in large errors in quantitation by MRS. NMR in Biomedicine, 16(2), 96-101. doi:10.1002/nbm.815 es_ES
dc.description.references Chen, J.-H., Enloe, B. M., Xiao, Y., Cory, D. G., & Singer, S. (2003). Isotropic susceptibility shift under MAS: The origin of the split water resonances in1H MAS NMR spectra of cell suspensions. Magnetic Resonance in Medicine, 50(3), 515-521. doi:10.1002/mrm.10569 es_ES
dc.description.references Cheng, L. L., Anthony, D. C., Comite, A. R., Black, P. M., Tzika, A. A., & Gonzalez, R. G. (2000). Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. Neuro-Oncology, 2(2), 87-95. doi:10.1215/s1522851799000447 es_ES
dc.description.references Cheng, L. L., Ma, M. J., Becerra, L., Ptak, T., Tracey, I., Lackner, A., & Gonzalez, R. G. (1997). Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proceedings of the National Academy of Sciences, 94(12), 6408-6413. doi:10.1073/pnas.94.12.6408 es_ES
dc.description.references Coen, M., Hong, Y.-S., Cloarec, O., Rhode, C. M., Reily, M. D., Robertson, D. G., … Nicholson, J. K. (2007). Heteronuclear1H−31P Statistical Total Correlation NMR Spectroscopy of Intact Liver for Metabolic Biomarker Assignment:  Application to Galactosamine-Induced Hepatotoxicity. Analytical Chemistry, 79(23), 8956-8966. doi:10.1021/ac0713961 es_ES
dc.description.references Esmaeili, M., Bathen, T. F., Engebråten, O., Maelandsmo, G. M., Gribbestad, I. S., & Moestue, S. A. (2013). Quantitative31P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts. Magnetic Resonance in Medicine, 71(6), 1973-1981. doi:10.1002/mrm.24869 es_ES
dc.description.references Esteve, V., Celda, B., & Martínez-Bisbal, M. C. (2012). Use of 1H and 31P HRMAS to evaluate the relationship between quantitative alterations in metabolite concentrations and tissue features in human brain tumour biopsies. Analytical and Bioanalytical Chemistry, 403(9), 2611-2625. doi:10.1007/s00216-012-6001-z es_ES
dc.description.references Kinross, J. M., Holmes, E., Darzi, A. W., & Nicholson, J. K. (2011). Metabolic phenotyping for monitoring surgical patients. The Lancet, 377(9780), 1817-1819. doi:10.1016/s0140-6736(11)60171-2 es_ES
dc.description.references Kriat, M., Confort-Gouny, S., Vion-Dury, J., Sciaky, M., Viout, P., & Cozzone, P. J. (1992). Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A comparative study of the use of formate and TSP as concentration standards. NMR in Biomedicine, 5(4), 179-184. doi:10.1002/nbm.1940050404 es_ES
dc.description.references Martínez-Bisbal, M. C., Esteve, V., Martínez-Granados, B., & Celda, B. (2011). Magnetic Resonance Microscopy Contribution to Interpret High-Resolution Magic Angle Spinning Metabolomic Data of Human Tumor Tissue. Journal of Biomedicine and Biotechnology, 2011, 1-8. doi:10.1155/2011/763684 es_ES
dc.description.references Martínez-Bisbal, M. C., Martí-Bonmatí, L., Piquer, J., Revert, A., Ferrer, P., Llácer, J. L., … Celda, B. (2004). 1H and13C HR-MAS spectroscopy of intact biopsy samplesex vivo andin vivo1H MRS study of human high grade gliomas. NMR in Biomedicine, 17(4), 191-205. doi:10.1002/nbm.888 es_ES
dc.description.references Martínez-Bisbal, M. C., Monleon, D., Assemat, O., Piotto, M., Piquer, J., Llácer, J. L., & Celda, B. (2009). Determination of metabolite concentrations in human brain tumour biopsy samples using HR-MAS and ERETIC measurements. NMR in Biomedicine, 22(2), 199-206. doi:10.1002/nbm.1304 es_ES
dc.description.references Middleton, D. A., Bradley, D. P., Connor, S. C., Mullins, P. G., & Reid, D. G. (1998). The effect of sample freezing on proton magic-angle spinning NMR spectra of biological tissue. Magnetic Resonance in Medicine, 40(1), 166-169. doi:10.1002/mrm.1910400122 es_ES
dc.description.references Opstad, K. S., Bell, B. A., Griffiths, J. R., & Howe, F. A. (2008). An assessment of the effects of sample ischaemia and spinning time on the metabolic profile of brain tumour biopsy specimens as determined by high-resolution magic angle spinning1H NMR. NMR in Biomedicine, 21(10), 1138-1147. doi:10.1002/nbm.1296 es_ES
dc.description.references Payne, G. S., Troy, H., Vaidya, S. J., Griffiths, J. R., Leach, M. O., & Chung, Y.-L. (2006). Evaluation of31P high-resolution magic angle spinning of intact tissue samples. NMR in Biomedicine, 19(5), 593-598. doi:10.1002/nbm.1040 es_ES
dc.description.references Renault, M., Shintu, L., Piotto, M., & Caldarelli, S. (2013). Slow-spinning low-sideband HR-MAS NMR spectroscopy: delicate analysis of biological samples. Scientific Reports, 3(1). doi:10.1038/srep03349 es_ES
dc.description.references Sitter, B., Bathen, T. F., Singstad, T. E., Fjøsne, H. E., Lundgren, S., Halgunset, J., & Gribbestad, I. S. (2010). Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR in Biomedicine, n/a-n/a. doi:10.1002/nbm.1478 es_ES
dc.description.references Sitter, B., Sonnewald, U., Spraul, M., Fjösne, H. E., & Gribbestad, I. S. (2002). High-resolution magic angle spinning MRS of breast cancer tissue. NMR in Biomedicine, 15(5), 327-337. doi:10.1002/nbm.775 es_ES
dc.description.references Tessem, M.-B., Swanson, M. G., Keshari, K. R., Albers, M. J., Joun, D., Tabatabai, Z. L., … Kurhanewicz, J. (2008). Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using1H HR-MAS spectroscopy of biopsy tissues. Magnetic Resonance in Medicine, 60(3), 510-516. doi:10.1002/mrm.21694 es_ES
dc.description.references Waters, N. J., Garrod, S., Farrant, R. D., Haselden, J. N., Connor, S. C., Connelly, J., … Nicholson, J. K. (2000). High-Resolution Magic Angle Spinning 1H NMR Spectroscopy of Intact Liver and Kidney: Optimization of Sample Preparation Procedures and Biochemical Stability of Tissue during Spectral Acquisition. Analytical Biochemistry, 282(1), 16-23. doi:10.1006/abio.2000.4574 es_ES
dc.description.references Wider, G., & Dreier, L. (2006). Measuring Protein Concentrations by NMR Spectroscopy. Journal of the American Chemical Society, 128(8), 2571-2576. doi:10.1021/ja055336t es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem